These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6151763)

  • 1. [Somatostatin in active psoriatic arthritis].
    Dinter L; Müller W
    Z Rheumatol; 1984; 43(6):291-3. PubMed ID: 6151763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in the treatment of psoriatic arthritis.
    Gupta AK; Matteson EL; Ellis CN; Ho VC; Tellner DC; Voorhees JJ; McCune WJ
    Arch Dermatol; 1989 Apr; 125(4):507-10. PubMed ID: 2930208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic arthritis treated with oral colchicine.
    Seideman P; Fjellner B; Johannesson A
    J Rheumatol; 1987 Aug; 14(4):777-9. PubMed ID: 3668983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinoid in the treatment of psoriatic arthropathy: a pilot study].
    Rosenthal M
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1912-4. PubMed ID: 538432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of etretinate in psoriatic arthritis.
    Klinkhoff AV; Gertner E; Chalmers A; Gladman DD; Stewart WD; Schachter GD; Schachter RK
    J Rheumatol; 1989 Jun; 16(6):789-91. PubMed ID: 2778761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of growth hormone in plasma of psoriatic arthritis, psoriasis vulgaris and seronegative spondylarthritis].
    Partsch G; Schwarzer C; Dunky A; Mayer F; Gschnait F; Neumüller J; Eberl R
    Z Rheumatol; 1985; 44(6):267-9. PubMed ID: 2869626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin treatment of psoriatic arthritis.
    Matucci-Cerinic M; Lotti T; Cappugi P; Boddi V; Fattorini L; Panconesi E
    Int J Dermatol; 1988; 27(1):56-8. PubMed ID: 2894365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of psoriasis-arthritis with cyclosporin A, a new immunosuppressive agent].
    Müller W; Graf U
    Schweiz Med Wochenschr; 1981 Mar; 111(12):408-13. PubMed ID: 7221517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Bongartz T; Coras B; Vogt T; Schölmerich J; Müller-Ladner U
    Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe psoriasis with somatostatin: four years of experience.
    Venier A; De Simone C; Forni L; Ghirlanda G; Uccioli L; Serri F; Frati L
    Arch Dermatol Res; 1988; 280 Suppl():S51-4. PubMed ID: 2900624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in psoriatic arthritis: a retrospective study.
    Kragballe K; Zachariae E; Zachariae H
    Acta Derm Venereol; 1983; 63(2):165-7. PubMed ID: 6189337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
    Rosenthal M
    Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
    Antoni C; Krueger GG; de Vlam K; Birbara C; Beutler A; Guzzo C; Zhou B; Dooley LT; Kavanaugh A;
    Ann Rheum Dis; 2005 Aug; 64(8):1150-7. PubMed ID: 15677701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.